Christopher Van Tuyl, Chief Legal Officer of Immunovant, Inc. ($IMVT), made two open market sales of company shares in the last year, totaling nearly $291,000. His most recent sale occurred on December 18, 2025. These transactions rank 7,624th out of 11,678 individual insiders by sale value, well below the average of $8.6 million across 6.37 transactions per insider. He reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 18, 2026 | Immunovant, Inc. | $IMVT | Van Tuyl Christopher | Chief Legal Officer | S | Common Stock | 2877 | $24.97 | 147,053.0000 | 203,532,180 | 1.92% | 0.00% |
| Dec. 18, 2025 | Immunovant, Inc. | $IMVT | Van Tuyl Christopher | Chief Legal Officer | S | Common Stock | 8529 | $26.78 | 152,214.0000 | 175,276,526 | 5.31% | 0.00% |
| Dec. 18, 2025 | Immunovant, Inc. | $IMVT | Van Tuyl Christopher | Chief Legal Officer | S | Common Stock | 2284 | $27.38 | 149,930.0000 | 175,276,526 | 1.50% | 0.00% |
| April 1, 2025 | Immunovant, Inc. | $IMVT | Van Tuyl Christopher | Chief Legal Officer | A | Stock Option (right to buy) | 71531 | $0.00 | 71,531.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2025 | Immunovant, Inc. | $IMVT | Van Tuyl Christopher | Chief Legal Officer | A | Common Stock | 50787 | $0.00 | 160,743.0000 | 0 | 46.19% | 0.00% |
| Dec. 16, 2024 | Immunovant, Inc. | $IMVT | Van Tuyl Christopher | Chief Legal Officer | A | Stock Option (right to buy) | 137446 | $0.00 | 137,446.0000 | 0 | 9999.99% | 0.00% |
| Dec. 16, 2024 | Immunovant, Inc. | $IMVT | Van Tuyl Christopher | Chief Legal Officer | A | Common Stock | 109956 | $0.00 | 109,956.0000 | 0 | 9999.99% | 0.00% |